IR contact detailsRoman Akbar-HaaseDirector Investor Relations and Business Developmente: ir@moonlaketx.com Upcoming events Sep 9 - Sep 10 2026 Citi's 2026 Biopharma Back to School Conference Sep 9 - Sep 11 2026 Cantor Global Healthcare Conference Sep 14 - Sep 16 2026 H.C. Wainwright 28th Annual Global Investment Conference View All Events View All Events + Corporate presentations MoonLake Investor Day (Jun 2026) MoonLake Investor Day (Feb 2026) Clinical Data Update (Nov 2025) View All Presentations View All Presentations + Latest press releases Aug 10 2026 MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results Jun 23 2026 MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering Jun 22 2026 MoonLake Immunotherapeutics Announces Proposed Public Offering View All News View All Press Releases +
Aug 10 2026 MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results